\
&
Contact us
\
&
Contact us
This was 3 months ago
LocationOnline
ProgrammesThe project Enhancing Opportunities for All*is organising a webinar and an online matchmaking session.
This 3rd event will take place virtually on March 12th, 2025, from 1:00PM to 6:00PM CET, and will be introduced by a webinar session on EDF proposal preparation in the morning, from 11:00AM to 12:00PM CET.
The link to register and participate is the following: https://server.matchmaking-studio.com/en/EuropeanDefenceFundMatchmakingDayMarch2025/.
This matchmaking event enables EDF potential applicants to reach out to partners and to prepare the EDF 2025 calls. This is also your chance to get meetings with NFPs and ask your questions regarding several aspects such as the scope of their project, funding rates, eligibility of partners, costs, etc.
*“Enhancing Opportunities for All” (EOA) is a project funded by the European Defence Fund with two main objectives: enhancing skills network and tools for National Focal Points (NFPs) and supporting possible applicants for EDF projects to engage in consortia.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
